Example: Heart Attack

Clinical Trials on Pars Planitis

Total 53 results

NCT04126850

Not yet recruiting

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease

Conditions: Autoimmune Uveitis; Behçet Disease; Vogt-Koyanagi-Harada Disease; Idiopathic Uveitis; Noninfectious Panuveitis; Anterior Uveitis Idiopathic; Posterior Uveitis; Intermediate Uveitis
NCT04120311

Recruiting

Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Conditions: Macular Edema; Radiation Retinopathy; Branch Retinal Vein Occlusion; Epiretinal Membrane; Central Serous Retinopathy With Pit of Optic Disc; Commotio Retinae; Vitritis
NCT04120636

Recruiting

Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Conditions: Macula Edema; Radiation Retinopathy; Branch Retinal Vein Occlusion; Epiretinal Membrane; Central Serous Retinopathy With Pit of Optic Disc; Commotio Retinae; Vitritis
NCT03656692

Suspended

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

Conditions: Uveitis, Posterior; Uveitis, Intermediate; Panuveitis
NCT03097315

Completed

Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis

Conditions: Uveitis; Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; Panuveitis
NCT02952001

Completed

Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

Conditions: Uveitis; Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; Panuveitis
NCT02931175

Recruiting

ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)

Conditions: Uveitis
NCT02911116

Recruiting

Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)

Conditions: Uveitis
NCT02879084

Unknown status

Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis

Conditions: Anterior Uveitis; Intermediate Uveitis
NCT02764697

Completed

Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

Conditions: Uveitis; Anterior Uveitis; Intermediate Uveitis; Posterior Uveitis; Scleritis; Clinically Significant Macular Edema
NCT02746991

Completed

Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

Conditions: Posterior Uveitis; Intermediate Uveitis; Panuveitis
NCT02595398

Completed

Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

Conditions: Uveitis; Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; Panuveitis
NCT02375685

Terminated

Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)

Conditions: Chronic Uveitis
NCT02258854

Terminated

An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

Conditions: Uveitis
NCT02255032

Completed

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

Conditions: Uveitis; Macular Edema; Uveitis, Posterior; Uveitis, Anterior; Panuveitis; Uveitis, Intermediate
NCT02125266

Terminated

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

Conditions: Uveitis, Posterior; Uveitis, Intermediate
NCT02049476

Completed

Study of the Effectiveness of Ozurdex for the Control of Uveitis

Conditions: Uveitis, Intermediate; Uveitis, Posterior
NCT01905124

Withdrawn

Safety &Efficacy of CF101 to Subjects With Uveitis

Conditions: Uveitis, Posterior; Uveitis, Intermediate
NCT01789320

Completed

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Conditions: Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis; Noninfectious Uveitis
NCT01747538

Terminated

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

Conditions: Uveitis
NCT01717170

Unknown status

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Conditions: Intermediate Uveitis; Posterior Uveitis; Pan-uveitis
NCT01684345

Terminated

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Conditions: Uveitis
NCT01526889

Completed

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

Conditions: Non-infectious Intermediate Uveitis; Non-infectious Posterior Uveitis; Non-infectious Panuveitis
NCT01376362

Completed

Topical Interferon Gamma for Macular Edema Secondary to Uveitis

Conditions: Anterior Uveitis; Uveitis
NCT01327664

Withdrawn

Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis

Conditions: Uveitis
NCT01314469

Completed

Quality of Life in Patients With Intermediate Uveitis

Conditions: Macular Edema
NCT01280669

Recruiting

Intravitreal Sirolimus as Therapeutic Approach to Uveitis

Conditions: Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis
NCT01170481

Completed

Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema

Conditions: Uveitis; Glaucoma
NCT01148225

Completed

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis

Conditions: Uveitis
NCT01138657

Completed

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

Conditions: Uveitis
NCT01124838

Completed

Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis

Conditions: Uveitis
NCT01109433

Terminated

Immunogenetic Mechanisms in Behcet's Disease

Conditions: Behcet's Disease; Uveitis
NCT01103024

Terminated

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Conditions: Uveitis
NCT01095250

Terminated

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Conditions: Uveitis
NCT01092533

Completed

Myfortic for the Treatment of Non-infectious Intermediate Uveitis

Conditions: Uveitis, Intermediate
NCT01090310

Terminated

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Conditions: Non-infectious Uveitis
NCT01032915

Terminated

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Conditions: Non-infectious Uveitis
NCT00995709

Completed

Phase III Study in Refractory Behcet's Disease

Conditions: Behcet Disease
NCT00943982

Completed

The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma

Conditions: Uveitis
NCT00908466

Completed

Sirolimus as Therapeutic Approach to Uveitis

Conditions: Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis
NCT00685399

Completed

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Conditions: Non-infectious Uveitis
NCT00615693

Completed

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Conditions: Uveitis; Posterior Uveitis; Panuveitis
NCT00570830

Completed

Retisert and Cataract Surgery in Patients With Severe Uveitis

Conditions: Intermediate Uveitis; Posterior Uveitis
NCT00539370

Completed

Human Samples and Data Repository

Conditions: Uveitis; Scleritis
NCT00499551

Withdrawn

A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis

Conditions: Uveitis
NCT00404612

Completed

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

Conditions: Uveitis, Posterior; Uveitis, Intermediate; Panuveitis
NCT00404742

Completed

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Conditions: Uveitis, Posterior; Uveitis, Intermediate; Panuveitis
NCT00344253

Completed

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

Conditions: Uveitis, Intermediate; Macular Edema; Multiple Sclerosis
NCT00333814

Completed

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Conditions: Intermediate Uveitis; Posterior Uveitis
NCT00331331

Completed

The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

Conditions: Uveitis; Vasculitis; Ocular Inflammatory Disease

Clinical Trials on Pars Planitis

Recent CRA jobs

CRA Line Manager - Home Based - California, Arizona or Nevada

Clinical Research Associate II, Greece

Assoc Clin Sys Support Spec

Associate Scientist - HPLC

CDM Programmer II - CDP (SAS)

Country Approval Spec - Netherlands

Sr Data Analyst

Clinical Trial Assistant - Verona or Milan - Client-dedicated

Contract Administrator II (28 hours per week)

Senior Scientist - HPLC UPLC KF and cGMP